Multicentre phase 2 study of neoadjuvant oxaliplatin and capecitabine followed by chemo-radiotherapy in patients with locally advanced carcinoma of esphago-gastric junction. Studio multicentrico di fase II, di chemioterapia di induzione con Oxaliplatino e Capecitabina seguito da chemio-radioterapia con intento neoadiuvante in pazienti affetti da carcinoma della giunzione esofago-gastrica localmente avanzato.

Trial Profile

Multicentre phase 2 study of neoadjuvant oxaliplatin and capecitabine followed by chemo-radiotherapy in patients with locally advanced carcinoma of esphago-gastric junction. Studio multicentrico di fase II, di chemioterapia di induzione con Oxaliplatino e Capecitabina seguito da chemio-radioterapia con intento neoadiuvante in pazienti affetti da carcinoma della giunzione esofago-gastrica localmente avanzato.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Jul 2014

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin
  • Indications Gastric cancer; Oesophageal cancer
  • Focus Therapeutic Use
  • Acronyms INOX-EGJ
  • Most Recent Events

    • 02 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top